AdAlta Limited (ASX:1AD)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Jul 15, 2026, 9:59 AM AEST
AdAlta Market Cap
AdAlta has a market cap or net worth of 11.9 million as of July 14, 2026. Its market cap has increased by 516.88% in one year.
Market Cap
11.90M
Enterprise Value
10.32M
Revenue
608.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since August 22, 2016, AdAlta's market cap has decreased from 28.00M to 11.90M, a decrease of -57.49%. That is a compound annual growth rate of -8.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 11.90M | 72.87% |
| Dec 31, 2025 | 6.89M | -31.84% |
| Dec 30, 2024 | 10.10M | -19.94% |
| Dec 29, 2023 | 12.62M | -2.04% |
| Dec 29, 2022 | 12.88M | -45.79% |
| Dec 29, 2021 | 23.76M | -22.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 22.40M |
| NeuroScientific Biopharmaceuticals | 21.62M |
| EZZ Life Science Holdings | 21.18M |
| Argenica Therapeutics | 16.06M |
| Immuron | 14.05M |
| ReNerve | 13.78M |
| Cambium Bio | 11.07M |
| Vectus Biosystems | 9.84M |